PATENT CLAIM ANALYSIS

Application Number: 15765756
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "171000"]

Abstract:
The present invention relates to methods and pharmaceutical compositions for the treatment of choroidal neovascularisation. In particular, the present invention relates to a method of treating choroidal neovascularisation in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a mineralocorticoid receptor antagonist.

Claim (Index 2):
The method of  claim 1  wherein the subject suffers from a disease selected from the group consisting of age-related macular degeneration, myopic choroidal neovascularization, idiopathic choroidal neovascularization, polypoidal chorioretinopathy associated or not to central serous chorioretinoapthy and some inflammatory conditions such as such uveitis posterior, traumatic choroidal rupture, angioid streaks, and ocular histoplasmosis syndrome.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14899162', '15616971', '11199374', '12457478', '14436727']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8082601550644323
- 35 USC 102 Novelty (BERT): 0.5153947090402077
- Combined Prediction Score: 0.7789736104620099
- Mean Citation Score: 277.300696
- Max Citation Score: 323.35165
- Similarity Product: 273.52551179521384

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test